Tectonic Therapeutic | Gewinn Vor Steuern

Aktienkurs
23.11
Täglich Wechseln
-0.82 -3.43%
Monatlich
13.45%
Jährlich
-9.62%
Q1 Prognose
20.71




Gewinn Vor Steuern Veränderung Datum
Akebia Therapeutics USD 6.11M 28.92M 2025-03
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Celltrion KRW 14.6B 180.89B 2025-06
Cspc Pharmaceutical CNY 1.21B 110.04M 2025-09
Dianthus Therapeutics USD -36.76M 5.13M 2025-09
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
Ionis Pharmaceuticals USD -228M 99M 2025-12
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
MacroGenics USD 16.82M 52.97M 2025-09
Medical Developments International AUD -149K 466K 2025-06
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pfizer USD 3.33B 290M 2025-09
Pharma Mar EUR -4.08M 27.43M 2025-09
Qiagen NV USD 134.73M 7.91M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Sartorius EUR 85M 14.1M 2025-09
Takeda JPY 133.86B 105.69B 2025-12
Tilray USD -1.39B 600.71M 2025-03
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06


Tectonic Therapeutic Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.